Provista Diagnostics Raises $6.0M
Scottsdale, Arizona-based Provista Diagnostics, a firm developing molecular diagnostics products aimed at predictive testing for cancer, said Tuesdya that it has raised $6.0M in a funding round. The Series A funding came from the firm's existing investors, according to the company. Names of those investors were not disclosed. Provista Diganotisc said it is developing a platform for predictive tests for cancers affecting women, including breast, endometrial and ovarian.
posted on Wednesday, April 17, 2013 (Link to more information)
Related companies:
Provista Diagnostics Inc.
Related stories:
> Provista Diagnostics Raises $5.0M
> BioFire Diagnostics Lands $25M For Molecular Diagnostics Tools
> MBio Diagnostics Gets $6M
> Co-Diagnostics Snags Patent
> Exagen Diagnostics Names COO
Techrockies.com Home